Senior counsel
Wilson Sonsini Goodrich & Rosati PC
Columns
| Title | Category | Published |
|---|---|---|
| Ruling may diminish ability to avoid induced infringement liability | Intellectual Property | Nov. 16, 2020 |
| FDA proposes rule clarifying evidence for determining product’s intended use | Administrative/Regulatory | Nov. 2, 2020 |
| EO to ensure drug rebates are passed down to patients | Health Care & Hospital Law, Administrative/Regulatory | Sep. 15, 2020 |
| The FDA and qualified health claims: a case study | Administrative/Regulatory | Aug. 12, 2020 |
| Bill would bring drugs that treat serious conditions to market faster | Health Care & Hospital Law | Jun. 16, 2020 |
| FDA, FTC issue joint statement on efforts to support market for biologics | Health Care & Hospital Law, Administrative/Regulatory | Feb. 24, 2020 |
MCLE
| Title | Category | Published |
|---|---|---|
| The FDA and qualified health claims: a case study | Administrative/Regulatory | Aug. 12, 2020 |
| Title | Category | Published |
|---|---|---|
| Ruling may diminish ability to avoid induced infringement liability | Intellectual Property | Nov. 16, 2020 |
| FDA proposes rule clarifying evidence for determining product’s intended use | Administrative/Regulatory | Nov. 2, 2020 |
| EO to ensure drug rebates are passed down to patients | Health Care & Hospital Law, Administrative/Regulatory | Sep. 15, 2020 |
| The FDA and qualified health claims: a case study | Administrative/Regulatory | Aug. 12, 2020 |
| Bill would bring drugs that treat serious conditions to market faster | Health Care & Hospital Law | Jun. 16, 2020 |
| FDA, FTC issue joint statement on efforts to support market for biologics | Health Care & Hospital Law, Administrative/Regulatory | Feb. 24, 2020 |
| Title | Category | Published |
|---|---|---|
| The FDA and qualified health claims: a case study | Administrative/Regulatory | Aug. 12, 2020 |
